Objectif In the Healthcare industry, digital health-care solutions will become vital in order to ensure a sustainable and efficient health system in both a time and cost effective manner. mySkin d.o.o aims to significantly contribute in creating innovative and sustainable principles in the Healthcare market, by improving the quality of life for acne sufferers and working conditions for medical professionals. mySkin proposes an innovative ICT concept for a digital skin-care service based on acne sufferers and dermatologists, applying new sets of rules, values and model to the health-care market, which ultimately disrupts the existing traditional skin care market. Up to now, acne assessment was only possible visiting dermatologist and traditional acne assessment was a time and money consuming procedure. Nowadays the progress of software solutions combined with the point of care devices can for the first time offer a better and cheaper alternative to the millions of acne sufferers and thousands of dermatologistsThe overall objective of ScanZ project is to move the system from technology readiness level 7 to 9, making the device clinically and commercially qualified for the market. The expected outcome of the project is to start the full commercialization of the ScanZ device at the end of PH2 as a medically certified IP protected user-centred designed system to be sold to hospitals. During the first medical trial at ORS Hospital Belgrade, mySkin obtained significant positive feedback from patients and medical professionals; and whilst scouting the dermatology clinics for holding medical trials during the PH2 project ScanZ has received strong interest from dermatology clinics across Europe as well as positive reviews from TechCrunch, CNET, NY Daily News, and the BBC. Champ scientifique medical and health sciencesclinical medicinedermatologymedical and health sciencesclinical medicineobstetricsmedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsantibioticsmedical and health sciencesbasic medicinepharmacology and pharmacydrug resistanceantibiotic resistancenatural sciencescomputer and information sciencessoftwaresoftware applications Mots‑clés digital medical device medical device acne diagnostic device point-of care devices acne sufferers imagining device health care acne assessment dermatology e-health m-health Programme(s) H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme H2020-EU.3.1.4. - Active ageing and self-management of health H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument H2020-EU.3.1.6. - Health care provision and integrated care Thème(s) SMEInst-06-2016-2017 - Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well Appel à propositions H2020-SMEInst-2016-2017 Voir d’autres projets de cet appel Sous appel H2020-SMEINST-2-2016-2017 Régime de financement SME-2 - SME instrument phase 2 Coordinateur MYSKIN DOO BEOGRAD (STARI GRAD) Contribution nette de l'UE € 1 613 347,75 Adresse KOSOVSKA 17/II 11000 Belgrade Serbie Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région Србија - север Београдски регион Београдска област Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 2 304 782,50